Amkay Products board to consider FY26 results on May 28

1 min read     Updated on 20 May 2026, 06:02 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Amkay Products Limited announced a board meeting on May 28, 2026, via VC/OAVM to approve audited financial results for the year ended March 31, 2026, and appoint an internal auditor for FY27. The trading window for designated personnel remains closed until 48 hours post-results announcement.

powered bylight_fuzz_icon
40825942

*this image is generated using AI for illustrative purposes only.

Amkay Products Limited has announced that its board meeting is scheduled to be held on May 28, 2026. The meeting will take place through video conferencing or other audio-visual means at 04.00 P.M. to discuss key agenda items pertaining to the company's financial and operational governance.

Agenda for the Meeting

The primary focus of the board will be to consider and approve the audited financial results of the company for the year ended March 31, 2026. Additionally, the directors will discuss the appointment of an internal auditor for the upcoming fiscal year 2026-27. The board may also consider any other matter with the permission of the Chair.

Trading Window Closure

In accordance with regulatory requirements, the company has informed that the trading window for dealing in the securities of the company by specified persons was closed effective April 1, 2026. This restriction will remain in effect and conclude 48 hours after the financial results are made public following the board meeting on May 28, 2026.

Meeting Details

Detail Information
Meeting Date May 28, 2026
Time 04.00 P.M.
Mode VC/OAVM
Financial Year End March 31, 2026

Historical Stock Returns for Amkay Products

1 Day5 Days1 Month6 Months1 Year5 Years
-3.17%+9.85%+7.02%+32.61%+35.56%-44.40%

How might Amkay Products Limited's audited financial results for FY2026 compare to the previous year's performance, and what growth trends could emerge?

What criteria will the board likely use in selecting a new internal auditor for FY2026-27, and could this signal a shift in the company's internal governance strategy?

How could the release of Amkay Products Limited's financial results influence investor sentiment and trading activity once the trading window reopens?

Amkay Products Limited Files Quarterly Compliance Certificate for Q4 FY26

1 min read     Updated on 06 Apr 2026, 09:42 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Amkay Products Limited submitted its quarterly compliance certificate under SEBI Regulation 74(5) for Q4 FY26 ended 31st March, 2026. The certificate from registrar Bigshare Services Pvt. Ltd. confirms the regulation is not applicable as all shares remain in demat form with no rematerialisation requests received during the quarter. The medical devices manufacturer fulfilled its regulatory obligations with BSE Limited through this compliance filing.

powered bylight_fuzz_icon
37037536

*this image is generated using AI for illustrative purposes only.

Amkay Products Limited has filed its quarterly compliance certificate with BSE Limited for the quarter and year ended 31st March, 2026. The submission fulfills the company's regulatory obligations under SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Certificate

The certificate was issued under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Bigshare Services Pvt. Ltd., serving as the company's Registrar and Share Transfer Agent, provided the compliance confirmation to Amkay Products Limited.

Parameter: Details
Regulation: SEBI Regulation 74(5)
Quarter Ended: 31st March, 2026
Registrar: Bigshare Services Pvt. Ltd.
BSE Scrip Code: 544169

Share Holding Status

According to the certificate issued by Bigshare Services Pvt. Ltd., the regulation is not applicable to the company as the entire holding of Amkay Products Limited's shares are maintained in demat form. The registrar confirmed that no requests were received from any members of the company for rematerialisation during the quarter ended 31st March, 2026.

Corporate Information

Amkay Products Limited operates as a manufacturer of medical devices and disposables. The company holds CE ISO 13485:2016 certification and maintains its registered office at Amkay Enclave, 68, Rashmi Park Bungalow, Dhumaal Nagar, Waliv Road, Vasai (East), Palghar, Maharashtra.

Authorisation Details

The compliance certificate was signed by Kashyap Pravin Mody, Managing Director of Amkay Products Limited (DIN: 01717036), and submitted to BSE Limited on 06/04/2026. Akash Shamal, Authorised Signatory from Bigshare Services Pvt. Ltd., authenticated the registrar's certificate confirming the demat status of all shareholdings.

Historical Stock Returns for Amkay Products

1 Day5 Days1 Month6 Months1 Year5 Years
-3.17%+9.85%+7.02%+32.61%+35.56%-44.40%

How might Amkay Products' complete transition to demat shareholding impact its future capital raising activities or stock liquidity?

What growth strategies is Amkay Products likely to pursue in the medical devices sector given the increasing demand post-pandemic?

Will Amkay Products consider expanding its CE ISO 13485:2016 certified manufacturing capabilities to serve international markets?

More News on Amkay Products

1 Year Returns:+35.56%